Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Jul;29(7):1031-9.
doi: 10.1007/s11606-014-2813-1. Epub 2014 Mar 8.

Comparative-effectiveness of revascularization versus routine medical therapy for stable ischemic heart disease: a population-based study

Harindra C Wijeysundera  1 , Maria C Bennell, Feng Qiu, Dennis T Ko, Jack V Tu, Duminda N Wijeysundera, Peter C Austin
Affiliations
Randomized Controlled Trial

Comparative-effectiveness of revascularization versus routine medical therapy for stable ischemic heart disease: a population-based study

Harindra C Wijeysundera et al. J Gen Intern Med. 2014 Jul.

Abstract

Background: Randomized studies have shown optimal medical therapy to be as efficacious as revascularization in stable ischemic heart disease (IHD). It is not known if these efficacy results are reflected by real-world effectiveness.

Objective: To evaluate the comparative effectiveness of routine medical therapy versus revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in stable IHD.

Design: Observational cohort study.

Patients: Stable IHD patients from 1 October 2008 to 30 September 2011, identified using a Registry of all angiography patients in Ontario, Canada.

Intervention: Revascularization, defined as PCI/CABG within 90 days after index angiography.

Main measures: Death, myocardial infarction (MI) or repeat PCI/CABG. Revascularization was compared to medical therapy using a) multivariable Cox-proportional hazard models with therapy strategy treated as a time-varying covariate; and b) a propensity score matched analysis. Post-angiography medication use was determined.

Key results: We identified 39,131 stable IHD patients, of whom 15,139 were treated medically, and 23,992 were revascularized (PCI = 15,604; CABG = 8,388). Mean follow-up was 2.5 years. Revascularization was associated with fewer deaths (HR 0.76; 95 % CI 0.68-0.84; p < 0.001) ,MIs (HR 0.78; 95 % CI 0.72-0.85; p < 0.001) and repeat PCI/CABG (HR 0.59; 95 % CI 0.50-0.70; p < 0.001) than medical therapy. In the propensity-matched analysis of 12,362 well-matched pairs of revascularized and medical therapy patients, fewer deaths (8.6 % vs 12.7 %; HR 0.75; 95 % CI 0.69-0.81; p < 0.001) , MIs (11.7 % vs 14.4 %; HR 0.84; 95 % CI 0.77-0.93 p < 0.001) and repeat PCI/CABG ( 17.4 % vs 24.1 %;HR 0.67; 95 % 0.63-0.71; p < 0.001) occurred in revascularized patients, over the 4.1 years of follow-up. The revascularization patients had higher uptake of clopidogrel (70.3 % vs 27.2 %; p < 0.001), β-blockers (78.2 % vs 76.7 %; p = 0.010), and statins (94.7 % vs 91.5 %, p < 0.001) in the 1-year post-angiogram.

Conclusions: Stable IHD patients treated with revascularization had improved risk-adjusted outcomes in clinical practice, potentially due to under-treatment of medical therapy patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study population.
Figure 2
Figure 2
a Propensity matched KM curves for survival. b Propensity matched cohort KM curves for Myocardial Infarction. c Propensity matched cohort KM curves for Repeat Revascularization.
See this image and copyright information in PMC

References

    1. Fraker TD, Jr, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol. 2007;50(23):2264–74. doi: 10.1016/j.jacc.2007.08.002. - DOI - PubMed
    1. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503–16. doi: 10.1056/NEJMoa070829. - DOI - PubMed
    1. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, Nallamothu BK, Kent DM. Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet. 2009;373(9667):911–8. doi: 10.1016/S0140-6736(09)60319-6. - DOI - PMC - PubMed
    1. Group BDS, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360(24):2503–15. doi: 10.1056/NEJMoa0805796. - DOI - PMC - PubMed
    1. Kereiakes DJ, Teirstein PS, Sarembock IJ, Holmes DR, Jr, Krucoff MW, O’Neill WW, et al. The Truth and Consequences of the COURAGE Trial. J Am Coll Cardiol. 2007;50(16):1598–603. doi: 10.1016/j.jacc.2007.07.063. - DOI - PubMed

Publication types

MeSH terms

Substances